Advertisement

Ads Placeholder
Loading...

Bristol-Myers Squibb Company

BMY•NYSE
Healthcare
Drug Manufacturers - General
$59.60
$-2.13(-3.45%)
U.S. Market opens in 3h 59m

Bristol-Myers Squibb Company (BMY) Stock Overview

Explore Bristol-Myers Squibb Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap121.4B
P/E Ratio17.25
EPS (TTM)$3.46
ROE0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$58.69
3 Months$42.30
1 Year Target$50.55

BMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bristol-Myers Squibb Company (BMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $50.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.25 and a market capitalization of 121.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.45%
5-Day Change
-0.02%
1-Month Change
-2.65%
3-Month Change
11.49%
6-Month Change
31.13%
Year-to-Date (YTD) Change
11.49%
1-Year Change
3.08%
3-Year Change
-14.48%
5-Year Change
-5.64%
All-Time (Max) Change
2835.96%

Contact Information

https://www.bms.com
609 252 4621
Route 206 & Province Line Road, Princeton, NJ, 08543

Company Facts

341,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions